Routine Screening Colonoscopy Should Stop at Age 75
For average-risk individuals who are up-to-date with prior screening, routine colorectal cancer screening colonoscopy should be discontinued at age 75 or when life expectancy falls below 10 years. 1
Age-Based Stopping Recommendations
Age 75: Standard Stopping Point
- Discontinue routine screening for average-risk adults older than 75 years who have been previously screened and have negative results 1
- This recommendation is based on the shift in risk-benefit ratio where procedural risks and overall mortality begin to outweigh potential life-expectancy benefits
- Life expectancy less than 10 years serves as an additional stopping criterion regardless of age 1
Ages 76-85: Selective, Individualized Approach
Between ages 76-85, screening decisions require careful consideration of:
- Prior screening history (particularly whether the patient has had any prior screening)
- Overall health status and comorbidities
- Patient preferences
- Life expectancy greater than 10 years
The USPSTF assigns this a Grade C recommendation, indicating the net benefit is small and screening should only be selectively offered rather than routinely recommended 1, 2
Age 86 and Older: Do Not Screen
Individuals ages 86 and older should NOT be offered colorectal cancer screening under any circumstances. 1 The overall mortality risk and adverse events from colonoscopy definitively outweigh any potential life-expectancy benefits at this age.
Age 85: Strong Discouragement
Clinicians should actively discourage individuals over age 85 from continuing screening 1
Key Clinical Considerations
Never-Screened Elderly Patients:
- For persons who have never been screened, consider screening up to age 85 depending on age and comorbidities 1
- This recognizes that previously unscreened individuals may have undetected advanced lesions
Previously Screened with Negative Results:
- Patients with prior negative high-quality colonoscopy have substantially lower risk and derive minimal benefit from continued screening after age 75 1, 3
Consensus Across Guidelines
All major guidelines (USPSTF, American Cancer Society, American College of Gastroenterology, American College of Physicians, Multi-Society Task Force) agree on:
- Age 75 as the standard stopping point for routine screening [1-2]
- Age 85 as an absolute upper limit beyond which screening should not occur 1
- The importance of life expectancy <10 years as a stopping criterion 1
Rationale for Stopping
The evidence supporting cessation is based on:
- Diminishing returns: Lead time for cancer detection to impact mortality decreases with advancing age
- Increasing procedural risks: Colonoscopy complication rates (perforation, bleeding, cardiovascular events) increase with age and comorbidity burden
- Competing mortality risks: Other causes of death become more likely than colorectal cancer mortality
- Quality of life: Screening-related harms may outweigh benefits in terms of remaining quality-adjusted life years